Your browser doesn't support javascript.
loading
Honokiol Inhibits Atrial Metabolic Remodeling in Atrial Fibrillation Through Sirt3 Pathway.
Liu, Guang Zhong; Xu, Wei; Zang, Yan Xiang; Lou, Qi; Hang, Peng Zhou; Gao, Qiang; Shi, Hang; Liu, Qi Yun; Wang, Hong; Sun, Xin; Liu, Cheng; Zhang, Peng; Liu, Hua Dong; Dong, Shao Hong.
Afiliación
  • Liu GZ; Department of Cardiology, Shenzhen Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen People's Hospital, Shenzhen, China.
  • Xu W; Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China.
  • Zang YX; Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Lou Q; Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Hang PZ; Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Gao Q; Department of Pharmacy, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.
  • Shi H; Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Liu QY; Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Wang H; Department of Cardiology, Shenzhen Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen People's Hospital, Shenzhen, China.
  • Sun X; Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China.
  • Liu C; Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Zhang P; Department of Cardiology, Shenzhen Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen People's Hospital, Shenzhen, China.
  • Liu HD; Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China.
  • Dong SH; Department of Cardiology, Shenzhen Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen People's Hospital, Shenzhen, China.
Front Pharmacol ; 13: 813272, 2022.
Article en En | MEDLINE | ID: mdl-35370645
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China